0001787297-22-000004.txt : 20220214
0001787297-22-000004.hdr.sgml : 20220214
20220214171408
ACCESSION NUMBER: 0001787297-22-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220210
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fotopoulos Alexandros
CENTRAL INDEX KEY: 0001799814
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39231
FILM NUMBER: 22634718
MAIL ADDRESS:
STREET 1: TWO COMMERCE SQUARE, 2001 MARKET STREET
STREET 2: 28TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Passage BIO, Inc.
CENTRAL INDEX KEY: 0001787297
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 822729751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE COMMERCE SQUARE
STREET 2: 2005 MARKET STREET, 39TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 2678660312
MAIL ADDRESS:
STREET 1: ONE COMMERCE SQUARE
STREET 2: 2005 MARKET STREET, 39TH FLOOR
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-02-10
0
0001787297
Passage BIO, Inc.
PASG
0001799814
Fotopoulos Alexandros
TWO COMMERCE SQUARE, 2001 MARKET STREET
28TH FLOOR
PHILADELPHIA
PA
19103
0
1
0
0
Chief Technical Officer
Common Stock
8383
D
Stock Option (right to buy)
4.52
2022-02-10
4
A
0
163900
0
A
2032-02-09
Common Stock
163900
163900
D
Includes 2020 Employee Stock Purchase Plan purchases of 1,495 shares that occurred since the date of the Reporting Person's last ownership report.
The stock option vests as to 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Edgar Cale, Attorney-in Fact
2022-02-14
EX-24
2
fotopoulospoa.txt
POWER OF ATTORNEY
LIMITED POWER OF ATTORNEY
The undersigned hereby constitutes and appoints Edgar Cale and Simona
King, as long as they are providing services to Passage Bio, Inc. or
its related entities (the "Company"), or either of them, the undersigned's
true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of the Company, Forms 3, 4 and 5 in
accordance with Section 16(a) of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), and the rules and regulations thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned
that may be necessary or desirable to complete and execute any such Forms
3, 4 and 5 and timely file such forms with the Securities and Exchange
Commission and any stock exchange or similar authority, if required; and
(3) take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit
to, in the best interest of, or legally required by, the undersigned, it
being understood that the documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as such attorney-in-
fact may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform each and every act and thing whatsoever
requisite, necessary or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as
the undersigned might or could do if personally present, with full power
of substitution and revocation, hereby ratifying and confirming all that
each such attorney-in-fact, or each such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted. The
undersigned acknowledges that each of the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, is not
assuming, nor is the Company assuming, any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act.
The undersigned agrees that each such attorney-in-fact may rely entirely
on information furnished orally or in writing by the undersigned to each
such attorney-in-fact. The undersigned also agrees to indemnify and hold
harmless the Company and each such attorney-in-fact against any losses,
claims, damages or liabilities (or actions in these respects) that arise
out of or are based on any untrue statement or omission of necessary facts
in the information provided by the undersigned to such attorney-in-fact
for purposes of executing, acknowledging, delivering and filing Forms 3, 4
or 5 (including amendments thereto) and agrees to reimburse the Company
and each such attorney-in-fact for any legal or other expenses reasonably
incurred in connection with investigating or defending against any such
loss, claim, damage, liability or action.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 14th day of February 2022.
/s/ Alexandros Fotopoulos
Name: Alexandros Fotopoulos